Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Pagoclone is an anxiolytic drug from the cyclopyrrolone family, which is related to other more well known drugs such as the sleeping medication zopiclone. It is one of a relatively... It is one of a relatively recently developed class of medicines known as the nonbenzodiazepines, which have similar effects to the older benzodiazepine group, but with quite different chemical structures.
- Mechanism
- Curator reviewed
Pagoclone is a subtype-selective drug which binds primarily to the alpha2/alpha3 subtypes of the GABAA receptor which are responsible for the anti-anxiety effects of these kind of drugs, but has relatively little efficacy at the alpha1 subtype which produces the sedative and memory loss effects.
- Primary indication
- For the potential treatment of panic and anxiety disorders.Curator reviewed
- Formula / weight
- C23H22ClN3O2 · 407.893 g/mol (avg)
Resolves to
HIUPRQPBWVEQJJ-UHFFFAOYSA-NSMILESCC(C)CCC(=O)CC1N(C(=O)C2=CC=CC=C12)C1=NC2=C(C=CC(Cl)=N2)C=C1What you can answer from here — as of January 29, 2025
Which drugs share a target with Pagoclone, and which of those have an active Phase 3 trial?